← SynDRA
CGP-53353
SynDRA canonical compound SYN0000217 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EGFR |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PKC inhibitor
- EGFR INHIBITOR
- PRKCB INHIBITOR
Cross-references
Synonyms
- CGP 53353
- DAPH-2
- DAPH-7
- CGP53353
- PKCbetaII/EGFR Inhibitor
- 5,6-BIS[(4-FLUOROPHENYL)AMINO]-1H-ISOINDOLE-1,3(2H)-DIONE
- CHEMBL7939
- CGP 53 353
- 4,5-bis(4-Fluoroanilino)-phthalimide
- CG53353
- 5,6-Bis((4-fluorophenyl)amino)isoindoline-1,3-dione
- 5,6-Bis[(4-fluorophenyl)amino]-2H-isoindole-1,3-dione
- 4,5-Bis(4-fluoroanilino)phthalimide
- 4,5-Bis[4-fluoroanilino]phthalimide
- PKCbII/EGFR Inhibitor
- AC1O8KXF
- 5,6-bis(4-fluoroanilino)isoindole-1,3-dione
- MolMap_000016
- CGP-53353, solid
- SCHEMBL230492
- Cgp53353
- RefChem:124824
- 1H-Isoindole-1,3(2H)-dione, 5,6-bis[(4-fluorophenyl)amino]-
- DAPH 7
- 1H-Isoindole-1,3(2H)-dione, 5,6-bis((4-fluorophenyl)amino)-
- GTPL5163
- orb1704624
- SCHEMBL29766901
- CHEBI:92560
- RONQPWQYDRPRGG-UHFFFAOYSA-N
- HMS3229K07
- HMS3269E05
- HMS3413M18
- HMS3677M18
- BDBM50040930
- AKOS015911570
- CCG-206784
- SB65936
- SDCCGSBI-0086704.P003
Look up CGP-53353 in the interactive SynDRA portal →